APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mono Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Mono Vaccine Industry Growth and Trends Forecast to 2032

22 December 202595 pages

Choose your research edition.

Industry ResearchMono Vaccine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Mono Vaccine Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Mono Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mono Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Mono Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Mono Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Mono Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Mono Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mono Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mono Vaccine include GSK, Merck, Pfizer, Serum Institute of India, Sanofi Pasteur MSD, Sanofi Pasteur, CNBG and Biokangtai, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Mono Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mono Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mono Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mono Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Mono Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mono Vaccine Market by Company

GSK

Merck

Pfizer

Serum Institute of India

Sanofi Pasteur MSD

Sanofi Pasteur

CNBG

Biokangtai

Mono Vaccine Segment by Type

Hepatitis Vaccine

Yellow Fever Vaccine

Cholera Vaccine

Meningococcal Vaccine

Japanese Encephalitis Vaccine

Other

Mono Vaccine Segment by Application

Adults

Children

Mono Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mono Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mono Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mono Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mono Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Mono Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Hepatitis Vaccine Table 2. Major Company of Yellow Fever Vaccine Table 3. Major Company of Cholera Vaccine Table 4. Major Company of Meningococcal Vaccine Table 5. Major Company of Japanese Encephalitis Vaccine Table 6. Major Company of Other Table 7. Global Mono Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Mono Vaccine Sales by Type (2021-2026) & (k units) Table 9. Global Mono Vaccine Sales Market Share in Volume by Type (2021-2026) Table 10. Global Mono Vaccine Sales by Type (2021-2026) & (US$ Million) Table 11. Global Mono Vaccine Sales Market Share in Value by Type (2021-2026) Table 12. Global Mono Vaccine Price by Type (2021-2026) & (US$/unit) Table 13. Global Mono Vaccine Sales by Type (2027-2032) & (k units) Table 14. Global Mono Vaccine Sales Market Share in Volume by Type (2027-2032) Table 15. Global Mono Vaccine Sales by Type (2027-2032) & (US$ Million) Table 16. Global Mono Vaccine Sales Market Share in Value by Type (2027-2032) Table 17. Global Mono Vaccine Price by Type (2027-2032) & (US$/unit) Table 18. North America Mono Vaccine Sales by Type (2021-2026) & (k units) Table 19. North America Mono Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Mono Vaccine Sales by Type (2021-2026) & (k units) Table 21. Europe Mono Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Mono Vaccine Sales by Type (2021-2026) & (k units) Table 23. Asia-Pacific Mono Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Mono Vaccine Sales by Type (2021-2026) & (k units) Table 25. Latin America Mono Vaccine Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Mono Vaccine Sales by Type (2021-2026) & (k units) Table 27. Middle East and Africa Mono Vaccine Sales by Type (2021-2026) & (US$ Million) Table 28. Mono Vaccine Industry Trends Table 29. Mono Vaccine Industry Drivers Table 30. Mono Vaccine Industry Opportunities and Challenges Table 31. Mono Vaccine Industry Restraints Table 32. Global Mono Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Mono Vaccine Revenue Market Share by Company (2021-2026) Table 34. Global Mono Vaccine Sales by Company (2021-2026) & (k units) Table 35. Global Mono Vaccine Sales Share by Company (2021-2026) Table 36. Global Mono Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 37. Global Mono Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Mono Vaccine Major Company Production Sites and Headquarters Table 39. Global Mono Vaccine Company, Product Type & Application Table 40. Global Mono Vaccine Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Mono Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Mono Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Mono Vaccine Sales by Region (2021-2026) & (k units) Table 45. Global Mono Vaccine Sales Market Share in Volume by Region (2021-2026) Table 46. Global Mono Vaccine Sales by Region (2021-2026) & (US$ Million) Table 47. Global Mono Vaccine Sales Market Share in Value by Region (2021-2026) Table 48. Global Mono Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 49. Global Mono Vaccine Sales by Region (2027-2032) & (k units) Table 50. Global Mono Vaccine Sales Market Share in Volume by Region (2027-2032) Table 51. Global Mono Vaccine Sales by Region (2027-2032) & (US$ Million) Table 52. Global Mono Vaccine Sales Market Share in Value by Region (2027-2032) Table 53. Global Mono Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 54. Global Mono Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Mono Vaccine Sales by Application (2021-2026) & (k units) Table 56. Global Mono Vaccine Sales Market Share in Volume by Application (2021-2026) Table 57. Global Mono Vaccine Sales by Application (2021-2026) & (US$ Million) Table 58. Global Mono Vaccine Sales Market Share in Value by Application (2021-2026) Table 59. Global Mono Vaccine Price by Application (2021-2026) & (US$/unit) Table 60. Global Mono Vaccine Sales by Application (2027-2032) & (k units) Table 61. Global Mono Vaccine Sales Market Share in Volume by Application (2027-2032) Table 62. Global Mono Vaccine Sales by Application (2027-2032) & (US$ Million) Table 63. Global Mono Vaccine Sales Market Share in Value by Application (2027-2032) Table 64. Global Mono Vaccine Price by Application (2027-2032) & (US$/unit) Table 65. North America Mono Vaccine Sales by Application (2021-2026) & (k units) Table 66. North America Mono Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Mono Vaccine Sales by Application (2021-2026) & (k units) Table 68. Europe Mono Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Mono Vaccine Sales by Application (2021-2026) & (k units) Table 70. Asia-Pacific Mono Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Mono Vaccine Sales by Application (2021-2026) & (k units) Table 72. Latin America Mono Vaccine Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Mono Vaccine Sales by Application (2021-2026) & (k units) Table 74. Middle East and Africa Mono Vaccine Sales by Application (2021-2026) & (US$ Million) Table 75. GSK Company Information Table 76. GSK Business Overview Table 77. GSK Mono Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. GSK Mono Vaccine Product Portfolio Table 79. GSK Recent Development Table 80. Merck Company Information Table 81. Merck Business Overview Table 82. Merck Mono Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Merck Mono Vaccine Product Portfolio Table 84. Merck Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Mono Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Pfizer Mono Vaccine Product Portfolio Table 89. Pfizer Recent Development Table 90. Serum Institute of India Company Information Table 91. Serum Institute of India Business Overview Table 92. Serum Institute of India Mono Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Serum Institute of India Mono Vaccine Product Portfolio Table 94. Serum Institute of India Recent Development Table 95. Sanofi Pasteur MSD Company Information Table 96. Sanofi Pasteur MSD Business Overview Table 97. Sanofi Pasteur MSD Mono Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Sanofi Pasteur MSD Mono Vaccine Product Portfolio Table 99. Sanofi Pasteur MSD Recent Development Table 100. Sanofi Pasteur Company Information Table 101. Sanofi Pasteur Business Overview Table 102. Sanofi Pasteur Mono Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Sanofi Pasteur Mono Vaccine Product Portfolio Table 104. Sanofi Pasteur Recent Development Table 105. CNBG Company Information Table 106. CNBG Business Overview Table 107. CNBG Mono Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. CNBG Mono Vaccine Product Portfolio Table 109. CNBG Recent Development Table 110. Biokangtai Company Information Table 111. Biokangtai Business Overview Table 112. Biokangtai Mono Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Biokangtai Mono Vaccine Product Portfolio Table 114. Biokangtai Recent Development Table 115. North America Mono Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 116. North America Mono Vaccine Sales by Country (2021-2026) & (k units) Table 117. North America Mono Vaccine Sales Market Share by Country (2021-2026) Table 118. North America Mono Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 119. North America Mono Vaccine Sales Market Share Forecast by Country (2027-2032) Table 120. North America Mono Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 121. North America Mono Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 122. North America Mono Vaccine Market Share by Country (2021-2026) Table 123. North America Mono Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 124. North America Mono Vaccine Market Share Forecast by Country (2027-2032) Table 125. Europe Mono Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 126. Europe Mono Vaccine Sales by Country (2021-2026) & (k units) Table 127. Europe Mono Vaccine Sales Market Share by Country (2021-2026) Table 128. Europe Mono Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 129. Europe Mono Vaccine Sales Market Share Forecast by Country (2027-2032) Table 130. Europe Mono Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. Europe Mono Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 132. Europe Mono Vaccine Market Share by Country (2021-2026) Table 133. Europe Mono Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. Europe Mono Vaccine Market Share Forecast by Country (2027-2032) Table 135. Asia-Pacific Mono Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 136. Asia-Pacific Mono Vaccine Sales by Country (2021-2026) & (k units) Table 137. Asia-Pacific Mono Vaccine Sales Market Share by Country (2021-2026) Table 138. Asia-Pacific Mono Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 139. Asia-Pacific Mono Vaccine Sales Market Share Forecast by Country (2027-2032) Table 140. Asia-Pacific Mono Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Asia-Pacific Mono Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 142. Asia-Pacific Mono Vaccine Market Share by Country (2021-2026) Table 143. Asia-Pacific Mono Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Asia-Pacific Mono Vaccine Market Share Forecast by Country (2027-2032) Table 145. Latin America Mono Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 146. Latin America Mono Vaccine Sales by Country (2021-2026) & (k units) Table 147. Latin America Mono Vaccine Sales Market Share by Country (2021-2026) Table 148. Latin America Mono Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 149. Latin America Mono Vaccine Sales Market Share Forecast by Country (2027-2032) Table 150. Latin America Mono Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Latin America Mono Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 152. Latin America Mono Vaccine Market Share by Country (2021-2026) Table 153. Latin America Mono Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Latin America Mono Vaccine Market Share Forecast by Country (2027-2032) Table 155. Middle East and Africa Mono Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 156. Middle East and Africa Mono Vaccine Sales by Country (2021-2026) & (k units) Table 157. Middle East and Africa Mono Vaccine Sales Market Share by Country (2021-2026) Table 158. Middle East and Africa Mono Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 159. Middle East and Africa Mono Vaccine Sales Market Share Forecast by Country (2027-2032) Table 160. Middle East and Africa Mono Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Middle East and Africa Mono Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 162. Middle East and Africa Mono Vaccine Market Share by Country (2021-2026) Table 163. Middle East and Africa Mono Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Middle East and Africa Mono Vaccine Market Share Forecast by Country (2027-2032) Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Mono Vaccine Distributors List Table 168. Mono Vaccine Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Mono Vaccine Image Figure 2. Global Mono Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mono Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Mono Vaccine Sales (2021-2032) & (k units) Figure 5. Hepatitis Vaccine Image Figure 6. Global Hepatitis Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 7. Yellow Fever Vaccine Image Figure 8. Global Yellow Fever Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 9. Cholera Vaccine Image Figure 10. Global Cholera Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 11. Meningococcal Vaccine Image Figure 12. Global Meningococcal Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 13. Japanese Encephalitis Vaccine Image Figure 14. Global Japanese Encephalitis Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 15. Other Image Figure 16. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 17. Global Mono Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Mono Vaccine Market Share by Type 2025 VS 2032 Figure 19. North America Mono Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. North America Mono Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Europe Mono Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Europe Mono Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Mono Vaccine Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Mono Vaccine Sales Market Share in Value by Type in 2025 Figure 25. Latin America Mono Vaccine Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Mono Vaccine Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Mono Vaccine Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Mono Vaccine Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Mono Vaccine Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Adults Image Figure 32. Global Adults Sales YoY Growth (2021-2032) & (k units) Figure 33. Children Image Figure 34. Global Children Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Mono Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Mono Vaccine Market Share by Application 2025 VS 2032 Figure 37. North America Mono Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. North America Mono Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Europe Mono Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Europe Mono Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Mono Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Mono Vaccine Sales Market Share in Value by Application in 2025 Figure 43. Latin America Mono Vaccine Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Mono Vaccine Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Mono Vaccine Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Mono Vaccine Sales Market Share in Value by Application in 2025 Figure 47. North America Mono Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Mono Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Mono Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Mono Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Mono Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Mono Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Mono Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Mono Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Mono Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Mono Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Mono Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Mono Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Mono Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Mono Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Mono Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Mono Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Mono Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Mono Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Mono Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Mono Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Mono Vaccine Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Mono Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Hepatitis Vaccine
  • Yellow Fever Vaccine
  • Cholera Vaccine
  • Meningococcal Vaccine
  • Japanese Encephalitis Vaccine
  • Other
Applications
  • Adults
  • Children
Companies covered
  • GSK
  • Merck
  • Pfizer
  • Serum Institute of India
  • Sanofi Pasteur MSD
  • Sanofi Pasteur
  • CNBG
  • Biokangtai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mono Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mono Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Mono Vaccine Market by Type
  6. 1.3.1 Hepatitis Vaccine
  7. 1.3.2 Yellow Fever Vaccine
  8. 1.3.3 Cholera Vaccine
  9. 1.3.4 Meningococcal Vaccine
  10. 1.3.5 Japanese Encephalitis Vaccine
  11. 1.3.6 Other
  12. 1.4 Global Mono Vaccine Market Size by Type
  13. 1.4.1 Global Mono Vaccine Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Mono Vaccine Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Mono Vaccine Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Mono Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Mono Vaccine Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Mono Vaccine Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Mono Vaccine Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Mono Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Mono Vaccine Industry Trends
  2. 2.2 Mono Vaccine Industry Drivers
  3. 2.3 Mono Vaccine Industry Opportunities and Challenges
  4. 2.4 Mono Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Mono Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Mono Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Mono Vaccine Price (2021-2026)
  4. 3.4 Global Mono Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mono Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Mono Vaccine Company, Product Type & Application
  7. 3.7 Global Mono Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mono Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mono Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mono Vaccine Tier 1, Tier 2, and Tier 3
4 Mono Vaccine Regional Status and Outlook
  1. 4.1 Global Mono Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Mono Vaccine Historic Market Size by Region
  3. 4.2.1 Global Mono Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Mono Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Mono Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Mono Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Mono Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Mono Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Mono Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mono Vaccine by Application
  1. 5.1 Mono Vaccine Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Children
  4. 5.2 Global Mono Vaccine Market Size by Application
  5. 5.2.1 Global Mono Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Mono Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Mono Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Mono Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Mono Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Mono Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Mono Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Mono Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Mono Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Mono Vaccine Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Mono Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Mono Vaccine Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Mono Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Mono Vaccine Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Serum Institute of India
  20. 6.4.1 Serum Institute of India Company Information
  21. 6.4.2 Serum Institute of India Business Overview
  22. 6.4.3 Serum Institute of India Mono Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Serum Institute of India Mono Vaccine Product Portfolio
  24. 6.4.5 Serum Institute of India Recent Developments
  25. 6.5 Sanofi Pasteur MSD
  26. 6.5.1 Sanofi Pasteur MSD Company Information
  27. 6.5.2 Sanofi Pasteur MSD Business Overview
  28. 6.5.3 Sanofi Pasteur MSD Mono Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Pasteur MSD Mono Vaccine Product Portfolio
  30. 6.5.5 Sanofi Pasteur MSD Recent Developments
  31. 6.6 Sanofi Pasteur
  32. 6.6.1 Sanofi Pasteur Company Information
  33. 6.6.2 Sanofi Pasteur Business Overview
  34. 6.6.3 Sanofi Pasteur Mono Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sanofi Pasteur Mono Vaccine Product Portfolio
  36. 6.6.5 Sanofi Pasteur Recent Developments
  37. 6.7 CNBG
  38. 6.7.1 CNBG Company Information
  39. 6.7.2 CNBG Business Overview
  40. 6.7.3 CNBG Mono Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CNBG Mono Vaccine Product Portfolio
  42. 6.7.5 CNBG Recent Developments
  43. 6.8 Biokangtai
  44. 6.8.1 Biokangtai Company Information
  45. 6.8.2 Biokangtai Business Overview
  46. 6.8.3 Biokangtai Mono Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Biokangtai Mono Vaccine Product Portfolio
  48. 6.8.5 Biokangtai Recent Developments
7 North America by Country
  1. 7.1 North America Mono Vaccine Sales by Country
  2. 7.1.1 North America Mono Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Mono Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Mono Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Mono Vaccine Market Size by Country
  6. 7.2.1 North America Mono Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Mono Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Mono Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Mono Vaccine Sales by Country
  2. 8.1.1 Europe Mono Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Mono Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Mono Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Mono Vaccine Market Size by Country
  6. 8.2.1 Europe Mono Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Mono Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Mono Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Mono Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Mono Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Mono Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Mono Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Mono Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Mono Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Mono Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Mono Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Mono Vaccine Sales by Country
  2. 10.1.1 South America Mono Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Mono Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Mono Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Mono Vaccine Market Size by Country
  6. 10.2.1 South America Mono Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Mono Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Mono Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Mono Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Mono Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Mono Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Mono Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Mono Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Mono Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Mono Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Mono Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Mono Vaccine Value Chain Analysis
  2. 12.1.1 Mono Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Mono Vaccine Production Mode & Process
  7. 12.2 Mono Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Mono Vaccine Distributors
  10. 12.2.3 Mono Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst